Grants and Contributions:
Title:
Development of a new oral formulation of DHEA
Agreement Number:
932356
Agreement Value:
$416,200.00
Agreement Date:
Aug 5, 2019 - Apr 30, 2022
Description:
Development of an innovative oral formulation of DHEA for the treatment of hot flashes in postmenopausal women.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Quebec, Quebec, CA G1V 4M7
Reference Number:
172-2019-2020-Q2-932356
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
850923327
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by -610 days. The total amended value is -233,640 dollars.
Amendment Date
Sep 8, 2022
Recipient's Legal Name:
Endoceutics inc.
Federal Riding Name:
Louis-Hébert
Federal Riding Number:
24044
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
3254
Amendments: